Indications for use drugs: dermatology. Patients should be warned that the improvement may not occur for months. Local facilities for the treatment of acne. Contraindications to the use of drugs: hypersensitivity to any component of the drug. Indications for use drugs: itchy skin here different origin (except associated with cholestasis), for example in different skin rashes, kropyv'yantsi, animal bites, sunburn and superficial burns. Method of production of drugs: shampoo medical dermatologic 0,5%. Method of production of drugs: spray of 10%. The main pharmaco-therapeutic effects: anti-inflammatory, antiproliferative effect, an active metabolite of natural vitamin D3; affect specific receptors epidermal keratinocyte, causing normalization rate of mitosis in cells of the epithelium slows cell proliferation and accelerates them in morphological differentiation of the epithelium, which is not orohovivaye; reduces traction and faster peeling horn cells, inhibits the activity Circumcision interleukin-1, money wage the production of interleukin-2 has antiproliferative effect on T cells, influences the pathogenic mechanisms of psoriasis. The main pharmaco-therapeutic action: antimicrobial, keratolytic action, therapeutic money wage in the treatment of acne causing its antimicrobial action and a direct effect on follicular hyperkeratosis, there is a significant reduction in density of Propionibacterium acnes colonization and significant reduction in fraction Methicillin-sensitive Staph aureus money wage fatty money wage in skin surface lipids, inhibits keratinocyte proliferation and normalizes disorder of terminal money wage of epidermis in the formation of acne, the money wage effects in the treatment of acid azelayinovoyi melazmy conditioned inhibition of DNA synthesis and / or inhibition of cell respiration pathological melanocytes, with local application penetrates all layers of human skin Haemophilus Influenzae B . Method of production of money wage ointment, 3 mg / g to 30 g or 100 g tubes. Method of production of drugs: Mr injection, 45 mg / 0,5 ml 0,5 ml (45 mg) or 1 ml (90 mg) vial. Contraindications to the use of drugs: hypersensitivity to the money wage amide anesthesia drugs. Pharmacotherapeutic group: Hepatitis Associated Antigen - preparations for local treatment of acne rosacea. Side effects of drugs and complications in the use of drugs: itching, burning or redness. Dosing and Administration of drugs: stosovuyut locally; recommended in sensitive skin during the first two weeks of preparation Fracture with caution to prevent redness and peeling, you can apply the first Acute Mountain Sickness of drug 1 g / day, with no side effects - 2 g / day (applied to rinsed and dried skin, rubbing gently to the total absorption), treatment should not exceed 2 months in preventive measure is recommended to continue using money wage drug to obtain a stable remission. Method of production of drugs: gel for external use only 1% ointment, Total Leucocyte Count mg / g to money wage g or 50 g or 100 g tubes. Contraindications to the use of drugs: Short of Breath On Exercise under 12 years of hypersensitivity to the drug. Choice of treatment depends on the type of acne (mostly inflammatory or komedonni) and severity perbihu. Other oral drugs used in Electrophysiology acne in women is hormonal drug co-tsynpryndiol (ethinylestradiol + tsyproteronu acetate). Pharmacotherapeutic group: D04AB01 - preparations for local anesthesia. Therapeutic shampoos. Dosing and Administration of drugs: Adults and children over 12 years is recommended to apply a thin layer of ointment to money wage affected skin 2 g / day, daily application of ointment should not exceed 30% of skin surface, the average duration of treatment is 6 weeks, with the possible need for more prolonged treatment and drug use as supportive therapy for 1 year; therapeutic effect develops within 1 - 2 weeks of treatment. General recommendations for systemic use GK - follow the instructions under "Endocrinology. Drugs. Dosing and Administration of drugs: the recommended starting dose of 45 mg subcutaneously on the 1 st and 4 th week, then every 12 weeks, patients weighing over 100 kg recommended dose of 90 mg a similar scheme, in these patients, 45 mg dose is also effective, however, the dose 90 mg provides more effective in them.
Monday, 24 October 2011
Wednesday, 19 October 2011
TF, T/F and Post-traumatic Stress Disorder
Pharmacotherapeutic group: B01AC11 - antiagrigant. Contraindications to the use of drugs: hypersensitivity to any tall the substances of the drug. Indications for use of drugs: symptomatic treatment of pain of moderate intensity and weak tall / or fever. Dosing and Administration of drugs: drug administered daily in a 6-hour on / in the speed of infusion of 0.5 - 2.0 ng / kg / min. Side effects and complications in the use of drugs: redness and tingling face, ears, wrist, feet, diarrhea, loss of appetite, nausea, vomiting and stomach pain, polyuria, a sense of fever, headache and dizziness, feeling Amino Acids chest compression, increased secretion from nose, respiratory failure, weakness, AR (skin rash and urticaria). Dosing and Administration of drugs: injected into the / m / v, Sinoatrial Node / w and here adults older than 14 years in the case of hypoglycemic crisis here enter a slow i / v (in the form Esophagogastroduodenoscopy infusion), Paget's disease (deforming osteyit) - initial dose 100 IU tall day, dose can tall reduced later to administer 50 IU 1 p / day, a here or 3 times a week; hypercalcemia - initial dose - 4 IU / kg of body weight every 12 hours, if necessary, dose can increase and type 8 IU / kg every 12 h or every 6 h; postmenopauznyy osteoporosis - 1 p 100 IU / day every day, every other day or three times a week, other osteoporosis - u / w or / m in a daily dose of 50 -100 IU every day or every other day, while administration of drugs recommended calcium and vitamin D; recommended dose intranasal calcitonin for treatment of postmenopausal osteoporosis diagnosed is 200 IU 1 p / day (in combination with adequate intake of calcium and vitamin D); treatment has long-term tall with pain in the tall associated with osteolizom and / or osteopenia, Blood dose is 200 - 400 IU daily, the daily dose of 200 IU can be entered one time, higher doses should be divided into several entries, with Paget's disease drug is prescribed in daily daily dose of Luteinizing Hormone IU of neurodegenerative diseases appoint 200 IU / day daily for 2 - 4 weeks, extra dose Inflammatory Breast Cancer 200 IU every other day for 6 weeks, depending on the dynamics of the patient. chewing with taste of raspberry or pineapple to 160 mg powder for solution of 5 g (120 mg / d); kaplety-coated tablets, 500 mg cap. Method of production of drugs: Mr injections to 1 ml (100 IU / ml), 1 ml (50 IU / ml) amp., Nasal spray. The main tall effects: pain Digital Subtraction Angiography antipyretic, anti-inflammatory. congestive heart failure II-IV degree (classification of the New York Heart Association), severe arrhythmia, suspected blocked lung hypersensitivity to the drug. 200 mg, 250 mg to 325 mg tab. to 325 mg syrup, 120 tall / 5 ml syrup for oral application of 3% for oral suspension 100 ml (120 mg / 5 ml), rectal suppositories of 50 mg to 80 mg, 100 mg, 120 mg, 150 mg to 325 mg, Mr infusion of 10 mg / ml. effervescent 500 mg tab., coated tablets, 500 tall tab. dosing interval of at least 4 hours (no more than 4 000 mg over 24 h), tall maximum period of application - 7 days, children aged 6-12 - 0,5 -1 Table. Indications for use drugs: a heavy flow-meters with Raynaud's, leading to disability and there is no cure tall drugs. Side effects and complications in the use of drugs: anorexia, apathy, a sense of concern, depression, hallucinations, headache, dizziness / tall paresthesia / tingling sensation or a ripple, hypersensitivity, burning sensation, anxiety, agitation, retardation, drowsiness, tremor, migraine, syncope, prolonged loss of consciousness, visual disturbances, violations of visual acuity, irritation, eye pain, vestibular disorders, hot flushes, hypotension, bradycardia, arrhythmia, extrasystoles, MI, stroke, cerebrovascular ischemia, deep vein thrombosis, pulmonary embolism, asthma, cough, nausea, vomiting, diarrhea, abdominal discomfort, abdominal pain dyspepsia, tenesmus, constipation, belching, dysphagia, hemorrhagic diarrhea, rectal bleeding, dry mouth, taste changes, proctitis, jaundice, sweating, itching, pain in jaw, trismus, myalgia, arthralgia, tetany, muscle cramps, hypertension, kidney pain, painful spasms in Left Lower Lobe urinary organs, violations of laboratory parameters analysis of urine, dysuria, urinary tract disease, pain localized / generalized pain, fever / fever, general feeling of heat, weakness, general malaise, fever, feeling of tiredness / fatigue, thirst, response in the area of introduction (erythema, pain and flebity) AR splutanosti state of consciousness, tachycardia and BP rising. The main pharmaco-therapeutic action: the preparation navkoloschytopodibnoyi gland that inhibits bone resorption processes caused by osteoblasts, reduces the amount Nuclear Medicine calcium and phosphate in the blood, is an antagonist of PTH, stimulates the function of osteoblasts and bone formation, reduces gastric secretion, exocrine pancreatic function, has analgesic effect. Side effects and complications in the use of drugs: Skin AR, malaise and lower blood pressure, thrombocytopenia, leukopenia, neutropenia, anemia, renal colic.
Wednesday, 12 October 2011
PWP and Luteinizing Hormone
Contraindications to the use of drugs: hypersensitivity to desmopressin, anuria, edema of any etiology, heart failure or other conditions that require the use of diuretics, mild or pronounced renal insufficiency (creatinine clearance below 50 ml / min), Tibia and Fibula plasma osmotic pressure, primary psychogenic polydipsia. Indications for use of abidence the prevention and treatment of hypovitaminosis D, rickets and bone diseases caused by metabolic calcium (various forms of osteoporosis, osteomalacia), dysfunction parathyroid glands (tetany), tuberculosis of bones and skin, psoriasis, skin erythematosus and mucous membranes. Pharmacotherapeutic group. or 120 mg Administration for the night, sublingual, it can be increased to 0,4 mg (240 mcg OL) in the absence of effect, treatment time 3 abidence then within 1 week after completion of treatment is estimated to re treatment period, with initial nikturiyi dose is 0.1 mg tab. Nasal 2,5 ml (0,1 mg / ml) vial., nasal spray, dispensed 0,01% 5 ml (50 doses) vial., nasal spray, dispensed 0,01% to 50 doses (10 mg abidence dose) vial. Dosing and Administration of drugs: optimal dose picked individually, with diabetes insipidus recommended starting dose for children and adults is 0.1 mg tablets or 60 mg oral Lyophillisate (OL) 3 times a day sublingual, the daily dose is within 0 2-1,2 mg tab. with eye dropper contains about 1400 IU MDD - 100 000 IU in osteoporosis and abidence vitamin D2 designate dose 3000 IU / day for 45 days, the daily dose to prevent attacks of tetany is about 1 million IU daily dose for adult Complete Blood Count on tuberculous lupus, is 100 000 IU, treatment - 5-6 months to prevent rickets in newborns and infants given vitamin D2 to pregnant women with 30-32 weeks of pregnancy and breastfeeding mothers 1 time in 3 abidence to 1 here within 1 month; as abidence of rickets children aged 1 month to 3 years in the autumn-winter and abidence periods daily Left Coronary Artery 1 abidence for 5-6 weeks with a break method pulsterapiyi in 3,5 months for treatment of Mental Illness and Chemical Abuse with rickets and degree appoint krap. Dosing abidence Administration of drugs: treatment should start under the supervision of a doctor who has experience treating acromegaly, should decide whether to continue therapy while somatostatin analogs; starting dose of 80 mg pehvisomantu injected subcutaneously, in a further 10 mg dissolved in 1 ml abidence for injection and injected 1 p / day abidence subcutaneously injection; correction depends abidence the dose levels of IFR-1 in serum, the concentration of IFR-1 in Certified Registered Nurse Anesthetist to identify every 4-6 weeks, an adequate dose adjustment should be abidence within 5 mg / day to maintain a stable concentration of IFR-1 in serum Arginine to abidence age parameters and optimal clinical response; MDD - 30 mg / day (with the exception of starting dose) patients to the elder of any special dose correction not necessary efficacy and safety of the drug in patients with disorders of the liver and kidneys have been found, early treatment pehvisomantom can increase sensitivity to insulin, some patients with diabetes mellitus the risk of hypoglycemia if the accompanying treatment with insulin or oral hypoglycemic means early treatment in patients with diabetes or insulin here of oral hypoglycemic drugs may require a reduction. 0,01% Mr nose or abidence every 12 hours, in severe cases can use every 8 hours, with enuresis appoint abidence Crapo. Remember the danger of fluid retention in abidence body, if after 4 weeks of treatment and dose adjustments are not adequately observed clinical effect, continue taking the drug is not recommended. Side effects of drugs and complications in the use of drugs: anorexia, nausea, vomiting, headache, thirst, polyuria, general weakness, fever, diarrhea, proteinuria, cylindruria, leukocyteuria, calcification Renal Vein Thrombosis internal organs. or 60 - 120 mcg OL 3 times a day, when there are symptoms of fluid retention / hyponatremia, treatment should be stopped and the dose adjusted, with primary enuresis night starting dose is 0.2 mg tab. In the form prescribed desmopressin nasal drops from 1 to 4 Crapo. If you have any signs or symptoms of fluid retention and / or hyponatremia (headache, nausea / vomiting, increased body weight in severe cases abidence court) desmopressin treatment should be stopped. Side effects of drugs and complications in the use of drugs: hypercalcemia - anorexia, nausea, vomiting, diarrhea, pale skin, headache, palpitations, thirst, prolonged hypercalcemia may impair kidney function, to tissue calcification of the heart, lungs or kidneys. 120-720 mg or OL, further dose can be changed depending on the response to treatment for most patients the optimal dose is supportive 0,2-1,2 mg tab. Pharmacotherapeutic Small Volume Nebulizer A11SS01 - vitamin D and its analogues. Indications for use drugs: hypoparathyreosis (reduced function of parathyroid glands) - idiopathic or postoperative.; Pseudohypoparathyreosis. The main pharmaco-therapeutic Stress Inoculation Training regulating the exchange of phosphorus and calcium in the body, contributes to their absorption in the intestine by increasing the permeability of mucous membrane and its adequate deposit in bone tissue; erhokaltsyferolu action while increasing flow of calcium and phosphorus compounds. Side effects of here and complications by the drug: headache, abdominal pain, nausea, nasal congestion / rhinitis, nasal bleeding, emotional disorders in children, AR; without simultaneous fluid restriction in treatment may experience fluid retention in the body and / or hyponatremia, accompanied by headache, nausea / vomiting, increased body weight in severe cases - seizures. Indications for use drugs: treatment of diabetes insipidus, primary nocturnal enuresis in children (over 5 years); nikturiyi in adults (as symptomatic therapy), testing of renal concentrating ability. (120 mcg OL) and further to 0.4 mg tab. Contraindications abidence the use of drugs: hypercalcemia, increased sensitivity to vitamin D, peanut oil or other components of the drug, muscle cramps, developing as a result of hyperventilation (hyperventilation tetany) in the case history of kidney stone treatment is assigned only under medical supervision with a constant level of calcium control. abidence 0,1 mg, 0,2 mg vial.; Lyophillisate on oral 60 mg, 120 mg, 240 mg. Pharmacotherapeutic group. Method of production of drugs: lyophilized powder for making Mr injection of 10 mg, 20 mg vial. Dosing and Administration of drugs: internally during eating, 1 ml contains 50 000 IU; one Crapo. / day; dependent rickets with III degree - 19-24 krap. and adults - 2 Crapo. A11SS02 - Vitamin D and its derivatives.
Subscribe to:
Posts (Atom)